ECSP993105A - THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM - Google Patents
THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEMInfo
- Publication number
- ECSP993105A ECSP993105A ECSP993105A ECSP993105A EC SP993105 A ECSP993105 A EC SP993105A EC SP993105 A ECSP993105 A EC SP993105A EC SP993105 A ECSP993105 A EC SP993105A
- Authority
- EC
- Ecuador
- Prior art keywords
- alkyl
- cycllohexylamine
- aryl
- nervous system
- central nervous
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title 1
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- -1 nitro, amino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere al uso de compuestos de la fórmula general (gráfico), en donde Ar1 representa fenilo, naftilo o tetarhidronaftilo, opcionalmente sustituidos por hidroxi, alcoxi-inferior, nitro, amino o matanosulfonamida; Ar2 representa fenilo, naftilo o tetrahidronaftilo, opcionalmente sustituidos por alquil-inferior o halógeno; X representa C, CH, C(OH) o N; Y representa -CH2-, CH u O Z -CH2-, -CH(CH3)- o -C(CH3)2-; R1 representa hidrógeno, alquil-inferior o acetilo; A representa C=0 o -(CHR2)n, en donde R2 representa hidrógeno, alquil-inferior o alquil-inferior-hidroxi; B representa -(CH2)n-, o, -CH(OH) (CH2)n, CH(CH2OH) (CH2)n-, -(CH2)n CH(OH)- o -CH(CH2OH)-; puede representar un enlace y n representa 0-4 y las sales de adición de ácido aceptables farmacéuticamente para la elaboración de medicamentos que representen indicaciones terapéuticas para bloqueadores específicos de subtipos de receptores NMDA.The present invention relates to the use of compounds of the general formula (graph), wherein Ar1 represents phenyl, naphthyl, or tetarhydronaphthyl, optionally substituted by hydroxy, lower alkoxy, nitro, amino, or matanosulfonamide; Ar2 represents phenyl, naphthyl, or tetrahydronaphthyl, optionally substituted by lower-alkyl or halogen; X represents C, CH, C (OH) or N; Y represents -CH2-, CH or O Z -CH2-, -CH (CH3) - or -C (CH3) 2-; R1 represents hydrogen, lower-alkyl or acetyl; A represents C = 0 or - (CHR2) n, where R2 represents hydrogen, lower-alkyl or lower-alkyl-hydroxy; B represents - (CH2) n-, or, -CH (OH) (CH2) n, CH (CH2OH) (CH2) n-, - (CH2) n CH (OH) - or -CH (CH2OH) -; may represent a bond and n represents 0-4 and pharmaceutically acceptable acid addition salts for the manufacture of medicinal products that represent therapeutic indications for specific blockers of NMDA receptor subtypes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993105 ECSP993105A (en) | 1999-08-18 | 1999-08-18 | THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993105 ECSP993105A (en) | 1999-08-18 | 1999-08-18 | THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993105A true ECSP993105A (en) | 2000-03-22 |
Family
ID=42044092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993105 ECSP993105A (en) | 1999-08-18 | 1999-08-18 | THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993105A (en) |
-
1999
- 1999-08-18 EC ECSP993105 patent/ECSP993105A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26782A1 (en) | DERIVATIVES OF BENZOTIAZOLE | |
| UY27092A1 (en) | DERIVATIVES OF THE NEW QUINUCLIDINE CARBAMATE AND THE MEDICINAL COMPOSITIONS CONTAINING THEM | |
| TR200101969T2 (en) | Substituted benzopyran analogs for the treatment of inflammation. | |
| UY27333A1 (en) | NUCLEOTIDOS 4` REPLACED | |
| BR0114253A (en) | Metabotropic Glutamate Receptor Antagonists | |
| AR020727A1 (en) | USE OF 3-AMINO-4-ARIL-MALEIMIDAS DERIVATIVE COMPOUNDS FOR THE PREPARATION OF MEDICINES FOR CONDITIONS ASSOCIATED WITH A NEED FOR INHIBITION OF LAGSK-3, SUCH COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM | |
| CR7743A (en) | NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| AR025444A1 (en) | DERIVATIVES OF SULFONIL-CARBOXAMIDE, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS | |
| AR035153A1 (en) | CARBOXAMID DERIVATIVES AND DIHYDROBENZODIOXINE KETONES | |
| SE0302760D0 (en) | New compounds | |
| PA8551001A1 (en) | NEW COMPOUNDS | |
| ATE512961T1 (en) | AMORPHIC NEBIVOLOL HYDROCHLORIDE AND ITS PRODUCTION | |
| EA200601194A1 (en) | NEW DERIVATIVES OF BENZOFURANE USED FOR THE PREVENTION OR TREATMENT OF DISTURBANCES ASSOCIATED WITH 5-HT-RECEPTOR | |
| AR012504A1 (en) | USE OF TETRAHYDROPYRIDINE DERIVATIVES, FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES WHICH CAUSE A DEMELINATION. | |
| UY28377A1 (en) | THERAPEUTIC AGENTS | |
| AR025046A1 (en) | IL-5 NON-STEROID INHIBITORS, PROCEDURES AND INTERMEDIARIES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITORS | |
| BR0312175A (en) | Compound, pharmaceutical composition, use of a compound, method of treatment and method for reducing morbidity and mortality associated with overweight | |
| AR050956A1 (en) | BENCIMIDAZOL DERIVATIVES; SYNTHESIS OF THE SAME; PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY LEGENDS OF THE CB1 RECEIVER. | |
| AR021770A1 (en) | THE USE OF ARILCICLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
| CL2004000779A1 (en) | COMPOUNDS DERIVED FROM 3-AZABICICLO [3.2.1] OCTANO, PHARMACEUTICAL COMPOSITION, PREPARATION PROCEDURE, USEFUL TO PREPARE MEDICATIONS TO TREAT IRRITABLE INTESTINE SYNDROME, RELEASE, NAUSEAS, VOMITES, SEXUAL DYSFUNCTION, ALZHE | |
| BRPI0412239A (en) | emulsifying systems containing azetidine derivatives | |
| ECSP993105A (en) | THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
| YU5899A (en) | Pyrolydine and piperidine derivatives, procedure for production thereof, their application for the production of medicines and the medicines containing them | |
| ES2172376B1 (en) | NEW DERIVATIVES OF ISOQUINOLEINS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| AR029666A1 (en) | USE OF (+) -ALFA- (2,3-DIMETOXIFENIL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINMETHANOL OR ITS DRUG FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND OF PSYCHOSIS INDUCED BY DOPAMINE |